|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2000-11-3
|
|
pubmed:abstractText |
The administration of GP IIb/IIIa antagonists has been shown to be effective in reducing myocardial infarction and cardial death when given before PTCA. This prospective study was performed to determine the efficacy of abciximab in a bail-out situation to manage threatened or acute vessel closure.
|
|
pubmed:language |
ger
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0300-5860
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
89
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
722-9
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:11013978-Aged,
pubmed-meshheading:11013978-Angina, Unstable,
pubmed-meshheading:11013978-Angioplasty, Balloon, Coronary,
pubmed-meshheading:11013978-Antibodies, Monoclonal,
pubmed-meshheading:11013978-Anticoagulants,
pubmed-meshheading:11013978-Coronary Angiography,
pubmed-meshheading:11013978-Female,
pubmed-meshheading:11013978-Follow-Up Studies,
pubmed-meshheading:11013978-Humans,
pubmed-meshheading:11013978-Immunoglobulin Fab Fragments,
pubmed-meshheading:11013978-Male,
pubmed-meshheading:11013978-Middle Aged,
pubmed-meshheading:11013978-Platelet Aggregation Inhibitors,
pubmed-meshheading:11013978-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:11013978-Prospective Studies,
pubmed-meshheading:11013978-Risk Factors,
pubmed-meshheading:11013978-Time Factors,
pubmed-meshheading:11013978-Vascular Patency
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
[Use of Abciximab in threatening vascular occlusion after PTCA].
|
|
pubmed:affiliation |
Universität Tübingen Medizinische Klinik Abt. III.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
English Abstract
|
